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Escherichia coli is the principal gram-negative causative agent of sepsis and meningitis in neonates. The
pathogenesis of meningitis due to E. coli K1 involves mucosal colonization, transcytosis of epithelial cells,
survival in the bloodstream, and eventually invasion of the meninges. The last two aspects have been well
characterized at a molecular level. Less is known about the early stages of pathogenesis, i.e., adhesion to and
invasion of epithelial cells. We have previously reported that the Hek protein causes autoaggregation and can
mediate adherence to and invasion of epithelial cells. Here, we report that Hek-mediated adherence is
dependent on binding to glycosoaminoglycan, in particular, heparin. The ability to hemagglutinate, autoag-
gregate, adhere, and invade is contingent on a putative 25-amino-acid loop that is exposed to the outside of the
bacterial cells.
Escherichia coli is the principal gram-negative causative
agent of sepsis and meningitis in neonates and is second only
to the group B streptococci overall. The strains that cause
these devastating infections are collectively known as neonatal
meningitic E. coli (NMEC), and among NMEC strains, those
expressing the K1 capsular antigen are predominant (13). E.
coli K1 accounts for up to 40% of E. coli sepsis and 80% of E.
coli meningitic isolates (29, 48) and generally results in a much
poorer clinical outcome than other NMEC strains (36). The
development of meningitis by E. coli K1 is a complex and
multifactorial process. Initial colonization of the mucosae is
followed by invasion and transcytosis of epithelial surfaces and
eventual accession to intravascular space (50). The bacteria
can then survive in the bloodstream, resulting in bacteremia,
which is a prerequisite for subsequent invasion of the blood-
brain barrier (BBB) (25). Inflammation accompanies the inva-
sion of the central nervous system and results in neuronal
damage, loss of integrity of the BBB, and pleocytosis (25).
Invasion of brain microvascular endothelial cells (BMECs),
which comprise the BBB, is a complex process, though over the
last decade much progress has been made in establishing the
bacterial and host factors that are involved (24, 25). BMECs
are efficiently invaded by NMEC, and this process is dependent
on the bacterial OmpA outer membrane protein binding to a
homolog of gp96 (43, 45, 46). In addition to its role as an
adhesin, OmpA also protects NMEC from immune defenses,
since these bacteria can multiply in macrophages and survive in
serum (42, 52, 54, 55). The CNF1 toxin also promotes bacterial
uptake (22). For both CNF1 and OmpA, bacterial uptake is
mediated by the induction of host cell signaling pathways (21).
A series of outer membrane proteins known as the Ibes and
other proteins, such as TraJ, AslA, and YijP, contribute to
invasion of the meninges (16–19). Aside from outer membrane
proteins, fimbriae (type 1 fimbriae and S fimbriae) also have
roles in attachment to BMECs (29, 44, 59). The K1 capsule is
required for survival during traversal of the BBB (15, 23) and
has a role in establishing high-level bacteremia (26).
Apart from endothelial cells, NMEC is known to interact
with epithelial cells. NMEC has been shown to invade bladder
epithelial cells, and this process requires cytoskeletal rear-
rangements (37). However, it is thought that the gastrointes-
tinal tract is the more essential site for initial colonization
leading to subsequent invasive disease (50). Transcytosis of
gastrointestinal cells, such as T84 or Caco-2, by NMEC has
been demonstrated and was maximal when cells were differ-
entiated and polarized (3). In common with bladder cell inva-
sion, transcytosis of gastrointestinal cells was also dependent
on cytoskeletal rearrangements. The factors that contribute to
gastrointestinal colonization, or more particularly invasion,
have not been unequivocally identified. However, a number of
novel factors, the so-called Dgcs, have been shown to be re-
quired for colonization (35).
We have previously shown that the Hek protein is expressed
by NMEC strain RS218 and is localized to the outer membrane
(9). This protein can cause agglutination of red blood cells and
can mediate autoaggregation. In addition, E. coli bacteria ex-
pressing the protein can adhere to and invade epithelial cells.
However, it is unknown what the protein binds to or what
amino acid sequences within the protein are required for ad-
hesion/invasion.
Glycosoaminoglycans (GAGs) are large linear molecules
composed of disaccharide repeats of hexosamine and sulfated
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galactose or hexuronic acid (2). The GAG chains are usually
covalently linked to a “core” transmembrane protein, thus
forming a proteoglycan. GAGs can be grouped into different
classes (heparin, heparan sulfate, dermatan sulfate, and chon-
droitin sulfate) based on the sugar composition and degree of
modification (2). Proteoglycans are expressed by all nucleated
cells and are often targets for binding by bacteria (49). Several
pathogens, including Neisseria gonorrhoeae (56), Bordetella per-
tussis (38), Mycobacteria spp. (38), and Listeria monocytogenes
(1), express surface proteins that recognize GAGs. Enterotoxi-
genic E. coli, a causative agent of traveler’s diarrhea, also
expresses a GAG-binding protein termed Tia (10, 11). Hek
and Tia are 62% identical, though much of the similarity be-
tween the proteins is in the transmembrane regions (12). To
our knowledge, Tia is not encoded by strains that have the hek
gene.
Here, we show that the receptor for Hek is proteoglycan, in
particular, heparinated proteoglycan. The ability to hemagglu-
tinate, autoagglutinate, adhere, and invade is contingent on a
putative 25-amino-acid loop that is exposed to the outside of
bacterial cells. To our knowledge, this is the first factor from
NMEC that utilizes this mechanism for adherence and inva-
sion.
(Portions of this work were presented at the 155th and
152nd meetings of the Society for General Microbiology.)
MATERIALS AND METHODS
Bacterial strains, plasmids, and culture conditions. E. coli strain XL-1 Blue
was used throughout this study. Bacterial plasmids are listed in Table 1. Bacteria
were routinely cultured in Luria (L) broth or on L agar plates (39), and stocks
were maintained in L broth supplemented with 8.7% (vol/vol) dimethyl sulfoxide
at "70°C. Strains were also grown in Dulbecco’s modified Eagle’s medium
(DMEM) or on Columbia agar plates containing 5% defribrinated horse blood
when indicated in the text. Where appropriate, antibiotics were added to media
at the following concentrations: carbenicillin, 50 #g/ml, and tetracycline, 30
#g/ml.
Eukaryotic cell lines and growth conditions. All cell lines used were obtained
from ATCC (Manassas, VA). The mammalian cells lines used were CHO-K1
(ATCC CCL-61) and pgsA-745 (ATCC CRL-2242) cells. Stocks of cell lines
were maintained in cell freezing medium-dimethyl sulfoxide (Sigma-Aldrich)
under liquid nitrogen. All cell lines were grown in a 1:1 mixture of DMEM and
Ham’s F-12 medium supplemented with 10% (vol/vol) heat-inactivated fetal
bovine serum (Life Technologies) at 37°C in 5% CO2.
Recombinant DNA techniques. Plasmid DNA was isolated using the Genelute
Plasmid Miniprep kit (Sigma-Aldrich) or the Qiagen Plasmid Midi kit, and total
genomic DNA was routinely purified using the Puregene genomic DNA purifi-
cation kit (Gentra Systems) according to the manufacturers’ instructions. Re-
striction endonucleases were purchased from New England Biolabs and used
according to the manufacturer’s instructions. Standard methods were used for
the ligation of DNA fragments and transformation of plasmid DNA (5, 7). The
synthesis of oligonucleotides and all DNA sequencing were performed by MWG
Biotech. Deletions within the hek gene of pHEK6 were made by inverse PCR
with Phusion polymerase using the primers listed in Table 2. These primers
contain the sequence CGC at their 5$ ends; when the products of inverse PCR
were religated, this resulted in a new BssHII site (CGCGCG). This sequence
encodes arginine followed by alanine, which is a turn-promoting sequence. The
products of inverse PCR were ligated and transformed into E. coli XL-1 Blue.
The deletions were verified by DNA sequencing.
Preparation and analysis of membrane proteins. Samples enriched for outer
membrane proteins were prepared as previously described (4). Briefly, 12 optical
density at 600 nm (OD600) units (corresponding to 4 ml of a culture with an
OD600 of 3) of bacteria were harvested by centrifugation at 6,000 % g for 10 min
and resuspended in 600 #l of sonication buffer (10% sucrose, 50 mM Tris-Cl [pH
7.5], 100 mM NaCl, 1 mM EDTA) and lysed by sonication. Intact bacteria were
removed by centrifugation at 9,300 % g for 5 min, and the supernatants were
incubated with 0.5% sarcosyl for 30 min with continuous mixing to solubilize the
inner membranes. The sarcosyl-insoluble fraction containing the outer mem-
branes was harvested by centrifugation at 21,000 % g for 30 min and resuspended
in 100 #l of Laemmli buffer. All protein samples were stored at "20°C and boiled
for 5 min prior to use. Protein samples were separated on discontinuous dena-
turing polyacrylamide gels by the method of Laemmli (30) and visualized fol-
lowing staining with Coomassie brillliant blue R-250. Alternatively, proteins were
transferred to Immobilon-P polyvinylidene difluoride membranes (Millipore)
using a Biometra Fastblot semidry transfer apparatus at 5 mA/cm2 for 20 min.
Protein transfer was confirmed by staining the membrane with Ponceau S. The
membranes were dried and incubated with a polyclonal primary anti-Hek anti-
serum raised in rabbits against a purified maltose-binding protein–Hek fusion
protein, diluted 1:2,000 in blocking buffer (3% nonfat powdered milk in phos-
phate-buffered saline [PBS] containing 0.01% Tween 20) for 1 h at room tem-
perature, followed by a secondary horseradish peroxidase-linked anti-rabbit an-
tibody diluted 1:20,000 for 30 min. The blot was developed using the SuperSignal
West Pico chemiluminescent horseradish peroxidase substrate (Pierce).
TABLE 1. E. coli plasmids used in this work
Plasmid Relevant details Reference
pBSKII Apr; ColE1 replicon Stratagene
pHEK6 Apr; 866 bp of RS218 DNA carrying the hek gene cloned into pBSK II 9
pLoop1 Apr; derivative of pHEK6 with the DNA sequence corresponding to the first loop
of the Hek protein replaced with CGCGCG
This work
pLoop2 Apr; derivative of pHEK6 with the DNA sequence corresponding to the second
loop of the Hek protein replaced with GCGCGC
This work
pLoop3 Apr; derivative of pHEK6 with the DNA sequence corresponding to the third
loop of the Hek protein replaced with GCGCGC
This work
pLoop4 Apr; derivative of pHEK6 with the DNA sequence corresponding to the fourth
loop of the Hek protein replaced with GCGCGC
This work
pTia5 Apr; tia gene from pET125 subcloned into pBSKII 9
pTm23 Apr; derivative of pHEK6 with the DNA sequence corresponding to
transmembrane strand 3 deleted.
This work
TABLE 2. Oligonucleotide primers used in this study
Primer
name Sequence
loop1F.......5$-GCG GTA TTC AGT GGC GGT ATT G-3$
loop1R ......5$-GCG TGA CAT CAC AGA GGC ACC-3$
loop2F.......5$-CGC GAG GTG TCA GTC AAC ACA CTA ATG-3$
loop2R ......5$-CGC CTC CAG TTC TGT ACG AAC CGG-3$
loop3F.......5$-CGC AAC TTC GCA TGG AGC CTT GG-3$
loop3R ......5$-CGC GGC GTA GCC AAT CCC TGC-3$
loop4F.......5$-CGC AAA AGT CAT GAC ATC ATG CTT GG-3$
loop4R ......5$-CGC ATC AAG ATA GCG ATA GCT GAG-3$
Tm3F ........5$-TTT TAC GCT CGT GGA AAA GCT GAT TCG-3$
Tm3R........5$-AAT ACC GCC ACT GAA TAC CGT ATC-3$
1136 FAGAN ET AL. INFECT. IMMUN.
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Amino-terminal sequencing of Hek. A sarcosyl-insoluble fraction containing
the Hek protein was separated on a discontinuous denaturing gel and transferred
to a Immobilon-P polyvinylidene difluoride membrane. The transferred protein
was stained by Ponceau S, and the section of membrane containing Hek was
excised. Sequencing was carried out by Alta Biosciences, Birmingham, United
Kingdom.
Flow cytometry. Surface exposure of the Hek protein on bacterial cells was
confirmed by flow cytometry using an anti-Hek polyclonal antiserum and a
fluorescently labeled secondary antibody. Briefly, approximately 5 % 107 bacteria
from an overnight culture were harvested at 18,000 % g for 10 min, washed three
times with PBS, and resuspended in PBS containing 2% (vol/vol) formaldehyde.
Excess formaldehyde was removed by three successive washes with PBS, and the
bacteria were then incubated overnight with a 1:10 dilution of absorbed anti-Hek
antiserum at 4°C. The labeled bacteria were then washed three times with PBS
and incubated with a 1:100 dilution of secondary fluorescein isothiocyanate-
conjugated anti-rabbit antibody for 1 h at room temperature. The labeled sam-
ples were then washed again as before, and fluorescence was analyzed on a
Beckman Coulter Epics XL flow cytometer according to the manufacturer’s
instructions.
Hemagglutination assays. The abilities of bacterial strains to agglutinate
erythrocytes were determined using a 1% suspension of human blood containing
100 mM mannose. Overnight bacterial cultures were harvested by centrifugation
at 15,800 % g for 1 min and resuspended in PBS to an OD600 of 1.0. The bacteria
were then serially twofold diluted with PBS in a final volume of 100 #l in a
96-well microtiter plate. To each well was added an equal volume of the 1%
blood suspension, and the plate was incubated at room temperature for 2 h or at
4°C overnight to allow unagglutinated erythrocytes to settle out of suspension.
Autoaggregation assays. Overnight cultures were harvested by centrifugation,
resuspended in PBS, and normalized to an OD600 of approximately 4.0. Five
milliliters of each culture was then transferred to a Kahn tube, and 50-#l samples
were taken from the surfaces of the cultures at regular intervals to determine the
OD600. Assays were performed in duplicate, and the rate of autoaggregation was
determined by the mean decrease in OD over time. Rates of autoaggregation
were determined using Kaleidagraph software.
Quantitative cell association and invasion assays. Cell association and inva-
sion assays were performed as previously described (6). CHO-K1 and pgsA-745
cells were seeded into 12-well trays at densities of 3.0 % 104 and 6.0 % 104 cells
per well, respectively, in DMEM/Ham’s F-12 medium supplemented with 10%
(vol/vol) heat-inactivated fetal bovine serum at 37°C in 5% CO2 and grown to
confluence.
Bacterial strains were grown overnight, washed with PBS, and diluted 1:500 in
warm tissue culture medium. All bacterial strains used in this study displayed
similar growth profiles and reached similar ODs (as determined by spectropho-
tometry) following overnight growth. The exact inoculum sizes following dilution
in tissue culture medium were determined by spreading dilutions on Columbia
blood agar plates and were comparable for all bacterial strains used. Mammalian
cell monolayers were washed once with warm PBS, and medium containing
bacteria (1 ml) was added to each well. The infected cells were centrifuged at
600 % g for 5 min to initiate contact between the bacterial and mammalian cells
and incubated at 37°C in 5% CO2 for 1 h to allow adhesion to and invasion of the
cultured cells. Infected monolayers were washed twice with warm PBS to remove
any nonadherent bacteria. To determine the total number of cell-associated
bacteria, the monolayer was disrupted by treatment with 0.1% Triton X-100 and
the released bacteria were enumerated by spreading dilutions on Columbia
blood agar plates. To determine the number of intracellular bacteria, a standard
gentamicin protection assay was performed (20). Following the 1-h infection,
cells were incubated with medium containing gentamicin (100 #g/ml) for 90 min
at 37°C in 5% CO2, washed with PBS, and disrupted with 0.1% Triton X-100, and
the released bacteria were enumerated as before. The cell association or invasion
efficiencies were expressed as the percentage of bacterial inocula recovered from
triplicate wells. Experiments were performed at least three times.
In experiments in which exogenous GAGs were tested as potential inhibitors
of invasion, the bacterial inocula were prepared as described previously in media
containing the inhibitor to be tested and incubated for 30 min to 1 h at 37°C prior
to infection of the cultured monolayers. The experiments were then carried out
as previously described.
Enzymatic treatment of cells. To further establish the significance of GAGs in
the Hek-mediated invasion of epithelial cells, eukaryotic cells were treated with
heparinase prior to gentamicin protection assays. CHO-K1 cells were incubated
at 37°C with heparinase III from Flavobacterium heparinum (75 mU/ml) for 3 h
prior to the addition of bacteria. Heparinase III is a heparin-degrading lyase that
recognizes heparin sulfate proteoglycan as its primary substrate, specifically
hydrolyzing the glycosidic linkage present in heparan sulfate (33). This lyase has
been shown to fully remove heparin moieties from proteoglycan core proteins
(11).
RESULTS
Hek directs the invasion of epithelial cells via interactions
with GAGs. Many pathogenic organisms have been shown to
utilize interactions with the ubiquitous mammalian cell surface
proteoglycans to both colonize and invade host tissues (12, 14,
49, 56). As stated above, the Tia invasin has identity with the
Hek protein, particularly in the eight transmembrane regions.
Tia mediates invasion by attaching to mammalian cell surface
proteoglycans (10). Interactions with proteoglycans generally
involve the GAG chains, for example, heparin and chondroitin
sulfate, which are linked to the core protein of the proteogly-
can. To examine if such interactions were important for Hek-
promoted invasion of epithelial cells, the ability of Hek-ex-
pressing bacteria to invade epithelial cells deficient in GAG
production or with reduced GAG expression was examined. In
the first instance, CHO-K1 cells were treated with heparinase
and the ability of Hek-expressing bacteria to invade these cells
was ascertained. Cells that had been treated with heparinase
were less well invaded (Fig. 1A). In fact, there was a greater
than 60% decrease in the frequency of invasion of CHO-K1
cells that had been treated with heparinase. pgsA-745 cells are
a CHO-K1 derivative that produces underglycosylated proteo-
glycans (8). Hek- or Tia-expressing E. coli K-12 bacteria are
efficiently internalized by CHO-K1 cells, as described previ-
ously (9); however, invasion by these bacteria was greatly re-
duced in the xylotransferase mutant cell line pgsA-745 (Fig.
1B). The magnitude of invasion for Hek-expressing bacteria
was reduced 23-fold in pgsA-745 cells.
In order to identify the specific GAG moiety involved in
Hek-mediated interactions with epithelial cells, the abilities of
different soluble GAG molecules to inhibit Hek-promoted in-
vasion of CHO-K1 cells were investigated. Inhibition was
tested with heparan sulfate, heparin (a more highly sulfated
form), and chondroitin sulfate, the most common GAGs found
on mammalian epithelial cell surfaces. The synthetic carbohy-
drate dextran sulfate (which is not a GAG) was included as a
negative control to discount nonspecific charge-charge inter-
actions, as it has a mass/charge ratio similar to that of heparin,
the most highly sulfated of the GAGs tested (41). When cells
were incubated with 10 #g/ml of GAG, only heparin was found
to inhibit uptake of Hek-expressing E. coli K-12 at a statisti-
cally significant level (Fig. 2A). Heparin reduced the number
of intracellular bacteria by 7.8-fold, whereas heparan sulfate,
chondroitin sulfate, and dextran sulfate reduced uptake by only
1.6-, 1.4-, and 1.6-fold, respectively. Inhibition of Hek-pro-
moted invasion by heparin was dose dependent and highly
sensitive, with considerable inhibition (2.5-fold) apparent with
as little as 100 ng/ml heparin (Fig. 2B). This suggests that Hek
interacts specifically with heparin GAG moieties. Interestingly,
heparan sulfate efficiently inhibited invasion at 100 #g/ml but
had little or no effect at 10 #g/ml (not shown), suggesting that
Hek is more specific for the more highly sulfated forms of
heparin.
Topology of the Hek protein. Amino-terminal sequencing of
the Hek protein, isolated from a sarcosyl-insoluble outer mem-
brane fraction, yielded the sequence KEGK, corresponding to
VOL. 76, 2008 THE Hek PROTEIN IS A GAG-BINDING ADHESIN 1137
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residues 23 to 26 of the predicted Hek sequence and consistent
with the cleavage of 22 amino acids upon inner membrane
translocation. The secondary structure of the 224-amino-acid
mature Hek protein was modeled using several computational
structural modeling tools, including PredictProtein (http://www
.embl-heidelberg.de/predictprotein/predictprotein.html) and
PORES (available upon request). The protein was predicted to
contain eight &-strands separated by alternating short (3 to 6)
or long (28 to 33) stretches of residues. A series of alternating
hydrophobic amino acids occupying every second position
along the strand can be found in each of the predicted
&-strands of the Hek protein in a manner characteristic of
&-barrel proteins (28). In support of the &-barrel prediction,
several of the &-strands are also flanked by aromatic residues
in a manner also characteristic of other &-barrel proteins (47,
51). Based on these observations, the Hek protein is likely to
adopt a &-barrel conformation in the outer membrane consist-
ing of eight antiparallel &-strands connected by four long ex-
ternal loops and three short periplasmic turns. The predicted
external loops were also found to contain a very high number
of charged residues compared to similar &-barrel proteins (27,
47, 58). Furthermore, the loops, or portions thereof, are pre-
dicted to be unstructured and disordered, as judged by using
GlobPlot (32). Amino acids E31 to D48 (loop 1), Y80 to R93
(loop 2), W142 to N162 (loop 3), and S194 to K198 (loop 4) are
predicted to be disordered, using Russell and Linding propen-
sities for disorder. A topological model of the Hek protein is
shown in Fig. 3, with the salient features highlighted, namely,
the transmembrane &-strands and the surface-exposed charged
residues.
The second surface-exposed loop of Hek is essential for all
Hek-promoted phenotypes. In silico modeling of the Hek pro-
tein tertiary structure predicted the presence of four long ex-
ternal loops linking the eight strands of the protein barrel on
the outer surface of the outer membrane. These four loops
comprise the only predicted surface-exposed portion of the
protein, and it can therefore be assumed that the biological
function of the protein resides in one or more of these loops.
In order to elucidate which of the loops play roles in the
various Hek-promoted phenotypes, a series of hek loop dele-
tion mutant genes were constructed, based on the pHEK6
plasmid, each lacking the coding sequence for a single loop. In
FIG. 1. Characterization of the Hek GAG receptor. (A) Invasion
of CHO-K1 cells by E. coli K-12 carrying pBSKII (white bar) or
pHEK6 (Hek!). Cells were treated with heparinase (gray bar) or not
treated with enzyme (black bar). !!, P ' 0.005 versus untreated
CHO-K1 cells. (B) Removal of heparin reduces Hek-mediated inva-
sion. Invasion of CHO-K1 (black bars) or pgsA-745 (gray bars) cells by
E. coli K-12 carrying pHEK6 (Hek!), pBSKII (vector control), or
pTia5 (Tia!). !, P ' 0.05 for invasion of pgsa-745 versus invasion of
CHO-K1 cells by Hek-expressing bacteria. The error bars indicate
standard deviations.
FIG. 2. Inhibition of Hek invasion by the addition of GAGs.
(A) Inhibition of CHO-K1 invasion by E. coli K-12 harboring pHEK6
using exogenous GAGs. Shown is the invasion of CHO-K1 cells by E.
coli K-12 carrying pHEK6 (black bar); E. coli K-12 carrying pHEK6
following incubation with 10 #g/ml of heparin (H), heparan sulfate
(HS), chondroitin sulfate (CS), or dextran sulfate (DS) (gray bars);
and E. coli K-12 harboring the vector control pBSKII. Bacteria were
incubated for 30 min with each inhibitor prior to the assay. The non-
GAG carbohydrate dextran sulfate was included as a negative control
of nonspecific charge-charge interactions. Invasion efficiencies were
expressed relative to the uninhibited control (normalized to 100%). !,
P ' 0.05 versus uninhibited control. (B) Inhibition of Hek-promoted
invasion using exogenous heparin. Shown is invasion of CHO-K1 cells
by E. coli K-12 carrying pHEK6 (black bar), E. coli K-12 carrying
pHEK6 in the presence of various concentrations of heparin (gray
bars), and E. coli K-12 harboring the vector control pBSKII (white
bar). The error bars indicate standard deviations.
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each case, the coding sequence for each loop was replaced with
two codons encoding arginine (CGC) and alanine (GCG), and
the extents of the resulting deletions are shown in Fig. 3.
Expression and surface exposure of each mutant protein was
confirmed by Western immunoblot analysis and flow cytometry
on intact bacterial cells using a polyclonal Hek-specific anti-
body (Fig. 4A). All four mutant proteins were expressed. For
those proteins lacking loop 1, 2, or 4, the level of expression
and surface localization was similar to that of wild-type Hek.
The mutant lacking the third loop was less well expressed than
the others and could be detected on the surfaces of recombi-
nant bacteria at a level 10-fold lower than that of wild-type
Hek. The ability of each to promote hemagglutination, auto-
aggregation, and invasion of CHO-K1 cells was assessed (Fig.
4B and Table 3). Deletion of the first loop had no discernible
effect on hemagglutination, autoaggregation, or invasion. De-
letion of the third loop abolished measurable hemagglutina-
tion and autoaggregation. The decreased levels of adhesion
and hemagglutination displayed by Hek lacking loop 3 can be
directly attributed to the decreased copy number of the protein
in the cell membrane. Notwithstanding this decrease in the
copy number of the loop 3 deletion mutant, E. coli K-12 ex-
pressing the mutant protein still efficiently invaded CHO-K1
cells at a level more than 50% of wild type. This may indicate
that there is a saturable level of Hek required for invasion.
Deletion of the fourth loop resulted in a protein that gave
intermediate levels of hemagglutination and autoaggregation.
Interestingly, deletion of this loop resulted in a protein that
conferred enhanced invasiveness on the bacteria. Thus, loop 4
may have a modulatory effect on invasion. Hek lacking loop 2
could not promote heamagglutination and had a much reduced
FIG. 3. Two-dimensional model of the topology of the membrane-spanning mature Hek protein. Residues predicted to belong to transmem-
brane &-strands are indicated with diamonds, and residues in unstructured loops are circled. The extent of each loop deletion mutation and the
position of the substituted alanine-arginine (AR) bridge used in each are indicated by hexagonal residues. Positively charged residues located in
the surface-exposed loops are highlighted in black, and negatively charged residues are in gray.
FIG. 4. Identification of the functional loop of Hek. (A) Expression
of the Hek loop deletion mutants (pLoop1 to -4) was confirmed by
Western immunoblot analysis using a Hek-specific polyclonal anti-
serum. Densitometry values, normalized to the level of full-length Hek
expression from pHEK6, are displayed below. The surface exposure of
each was determined by flow cytometry on intact bacterial cells using
the same anti-Hek antiserum and normalized to the fluorescence sig-
nal of bacteria expressing wild-type Hek. (B) Invasion of CHO-K1 cells
by E. coli K-12 carrying pBSKII (white bar), pHEK6 (black bar), or
each of the Hek loop deletion mutants (gray bars). The error bars
indicate standard deviations.
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level of autoagglutination. The levels of invasion promoted by
the protein were at vector control levels. Thus, loop 2 appears
to be the most important region for all activities of the Hek
protein.
Deletion of putative transmembrane !-sheets 2 and 3. The
Tia protein can bind to heparin using the sequence AVGYD
FYQHYNVPVRTEVE from amino acids 51 to 69. In our
model of Hek, the corresponding sequence is predicted to be
the second and third membrane-spanning &-strands of Hek
(Fig. 5). A deletion derivative of pHEK6, pTm23, lacking the
DNA encoding the sequence AVGYDFYPQFSIPVRTELE,
from amino acids 51 to 69, was constructed. Although a trun-
cated derivative, Hek(23, was expressed from this construct, it
did not insert into the outer membrane as judged by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis of sarcosyl-
enriched fractions or by flow cytometry (data not shown).
DISCUSSION
The pathogenesis of E. coli K1 neonatal meningitis is a
complex and multifaceted process. A great deal is now known
about the mechanism by which these organisms disseminate in
the bloodstream, establishing septicemia, and breach the BBB.
Considerably less is known about the initial stages of infection,
in particular, colonization and invasion of the epithelia. We
have previously described the first E. coli K1 factor to be
implicated in both adhesion to and invasion of cultured human
gastrointestinal epithelial cells (9). Hek is a 26-kDa protein
that is predicted to form an eight-stranded &-barrel in the
outer membrane of E. coli K1 strain RS218. Many pathogens
have been shown to exploit host cell proteoglycans, in partic-
ular heparin-containing proteoglycans, in order to enable col-
onization and invasion of host tissues. Several proteins from
pathogenic bacterial species implicated in this process bear a
striking resemblance to Hek, including the Tia protein of en-
terotoxigenic E. coli and the broader family of Opa proteins of
Neisseria spp. (10, 57). Although these similarities are mostly
confined to amino acids predicted to be located in the mem-
brane-spanning &-barrel, we undertook to determine if Hek
could also utilize these ubiquitous host cell structures to pro-
mote adhesion to and invasion of cultured epithelial cells.
We have shown that expression of Hek in E. coli K-12 strains
is sufficient to promote invasion of the human gastrointestinal
epithelial cell line T84 and the model epithelial cell line
CHO-K1 (9). Our results suggest that this process requires
interactions with heparin-containing proteoglycans on the host
cell surface. Pretreatment of CHO-K1 cells with heparinase
significantly decreased the efficiency of Hek-dependent inter-
nalization. In keeping with this observation, E. coli K-12 ex-
pressing Hek or Tia was significantly less invasive in pgsA-745
cells, a derivative of CHO-K1 cells that produces underglyco-
sylated proteoglycans. Inhibition of invasion with a number of
soluble GAGs was also greatest with heparin, and this inhibi-
tion was dose dependent, suggesting a specific interaction with
highly sulfated heparin proteoglycans. Heparin was also the
only GAG found to inhibit the interaction of E. coli strain K1
with CHO-K1 cells (R. P. Fagan and S. G. J. Smith, unpub-
lished observations). However, E. coli K-12 expressing Hek or
Tia was still significantly more invasive than the negative con-
trol in pgsA-745 cells. This suggests that Hek and Tia may be
capable of interacting with additional CHO-K1 cell surface
components. It is possible that the initial interaction between
the bacterial protein and a GAG moiety facilitates further
interactions with an additional cell surface component, per-
haps even with the core protein of the receptor proteoglycan,
which would still be present on the surfaces of pgsA-745 cells.
Computational modeling of the Hek protein is consistent
with an eight-stranded &-barrel with three short periplasmic
turns and four longer surface-exposed loops. As these loops
are the only predicted surface-exposed regions of the proteins,
it is reasonable to assume that some or all of the loops are
involved in mediating the various Hek-dependent phenotypes
described to date (9). Although no secondary structure was
predicted in the surface-exposed loops, the &-strands on either
side of the third loop were predicted to extend a considerable
distance beyond the membrane surface. Such an arrangement
may serve to extend and support the loop farther from the
membrane and to provide a support structure for the other
loops in a manner similar to that observed with OpcA in
Neisseria meningitidis and OmpX in E. coli (47, 51, 58). One
striking feature of the surface-exposed loops of Hek is the
extreme abundance of charged amino acids present, 20 basic
and 26 acidic residues. The presence of surface-exposed basic
residues has been shown to be involved in binding to proteo-
glycans (31), and in the case of OpcA in particular, the com-
bination of extended &-strand structure and an abundance of
basic residues resulted in the formation of a positively charged
cleft that is theorized to be the site of binding to heparinated
proteoglycans (47). Although the data gathered here do not
FIG. 5. Comparison of the Hek and Tia proteins. The amino acid
sequences of the mature forms of Hek and Tia were aligned by ClustalW.
The positions of putative loops are indicated, and positively charged
residues within loop 2 are marked by asterisks. The position of the
peptide used to inhibit Tia adhesion (34) and binding of heparin (10)
is underlined.
TABLE 3. Hemagglutination and autoaggregation by
Hek loop mutants
Parameter Hek" Hek!
With loop deleted
1 2 3 4
Hemagglutination titer 0 16 16 0 0 8
Autoaggregation rate
(10"3 OD600 units ! min
"1)
2.8 28.0 29.2 5.5 5.6 17.6
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allow any accurate prediction of the final structure of the
surface-exposed loops of Hek, they may play a similar role in
proteoglycan binding. Construction of a series of mutant Hek
proteins, each lacking a single loop, has allowed a detailed
analysis of the contribution of each to Hek-promoted hemag-
glutination, autoaggregation, and epithelial cell invasion. De-
letion of a single 28-amino-acid loop, loop 2, was found to
abrogate all three phenotypes. Individual deletions of the re-
maining three loops had little or no effect in the same assays.
These data suggest that the second surface-exposed loop is
essential for the interaction of Hek with its receptors, with only
minor contributions from the remaining surface-exposed por-
tions of the protein.
It has also been reported in the literature that the second
loop of the related Tia protein is involved in invasion (34) and
binding of heparin (10). The data are based on the abilities of
two short peptides (GYDFYQHYNVPVRTEVEFY and AV
GYDFYQHYNVPVRTEVEC) to inhibit invasion of HCT8
human epithelial cells by Tia-expressing bacteria. In addition,
these peptides bind directly to heparin-albumin-biotin. The
region corresponding to these peptides in Hek is predicted to
be a transmembrane &-strand and is rich in hydrophobic resi-
dues. In support of this prediction, a deletion of this region in
Hek yields a protein that is incapable of folding correctly and
inserting into the outer membrane. If this sequence in Hek is
also to engage in contacts with GAGs, it would suggest that the
&-barrel may have a pore of sufficient size to permit access of
the GAG chains. There is currently no evidence to support this
hypothesis.
Hek is not restricted to NMEC isolates. In one study, 55% of
urinary tract isolates were shown to have the hek gene (53).
Given that the Hek homolog Hra1 can bind to cells under
shear stress, it is tempting to speculate if Hek in these isolates
can promote uroepithelial adherence. Furthermore, we have
identified a protein in the recently completed sequence of the
enteroaggregative E. coli strain 042 that is 90% identical to
Hek. While aggregative adherence in enteroaggregative E. coli
is mediated by fimbriae (40), considering the aggregative na-
ture of Hek-mediated adherence, it may be that Hek contrib-
utes to this phenomenon. In addition, we have recently iden-
tified hek in 36% of a cohort of 221 bacteremic isolates of E.
coli.
Hek can contribute to invasion of epithelial cells, and we
have recently established that the OmpA and IbeB proteins of
E. coli K1 also mediate entry into gastrointestinal epithelial
cells (R. P. Fagan and S. G. Smith, unpublished data). For E.
coli causing meningitis, invasion may thus be a multifactorial
process involving several outer membrane adhesin/invasin pro-
teins.
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